View in EDS

Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.

Saved in:
Bibliographic Details
Title: Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
Authors: Turpin A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France., Delliaux C; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Parent P; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France., Chevalier H; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France., Escudero-Iriarte C; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Bonardi F; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000, Lille, France., Vanpouille N; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Flourens A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Querol J; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Carnot A; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France., Leroy X; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France., Herranz N; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Lanel T; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France., Villers A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France., Olivier J; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France., Touzet H; University Lille, CNRS, Centrale Lille, UMR 9189 CRIStAL, F-59000, Lille, France., de Launoit Y; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Tian TV; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Duterque-Coquillaud M; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. martine.duterque@cnrs.fr.
Source: British journal of cancer [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 1903-1914. Date of Electronic Publication: 2023 Oct 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37875732
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Turpin+A%22">Turpin A</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Delliaux+C%22">Delliaux C</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Parent+P%22">Parent P</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Chevalier+H%22">Chevalier H</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Escudero-Iriarte+C%22">Escudero-Iriarte C</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bonardi+F%22">Bonardi F</searchLink>; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Vanpouille+N%22">Vanpouille N</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Flourens+A%22">Flourens A</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Querol+J%22">Querol J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Carnot+A%22">Carnot A</searchLink>; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Leroy+X%22">Leroy X</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Herranz+N%22">Herranz N</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lanel+T%22">Lanel T</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Villers+A%22">Villers A</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Olivier+J%22">Olivier J</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Touzet+H%22">Touzet H</searchLink>; University Lille, CNRS, Centrale Lille, UMR 9189 CRIStAL, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22de+Launoit+Y%22">de Launoit Y</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Tian+TV%22">Tian TV</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Duterque-Coquillaud+M%22">Duterque-Coquillaud M</searchLink>; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. martine.duterque@cnrs.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 1903-1914. <i>Date of Electronic Publication: </i>2023 Oct 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37875732
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-023-02449-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1903
    Titles:
      – TitleFull: Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Turpin A
      – PersonEntity:
          Name:
            NameFull: Delliaux C
      – PersonEntity:
          Name:
            NameFull: Parent P
      – PersonEntity:
          Name:
            NameFull: Chevalier H
      – PersonEntity:
          Name:
            NameFull: Escudero-Iriarte C
      – PersonEntity:
          Name:
            NameFull: Bonardi F
      – PersonEntity:
          Name:
            NameFull: Vanpouille N
      – PersonEntity:
          Name:
            NameFull: Flourens A
      – PersonEntity:
          Name:
            NameFull: Querol J
      – PersonEntity:
          Name:
            NameFull: Carnot A
      – PersonEntity:
          Name:
            NameFull: Leroy X
      – PersonEntity:
          Name:
            NameFull: Herranz N
      – PersonEntity:
          Name:
            NameFull: Lanel T
      – PersonEntity:
          Name:
            NameFull: Villers A
      – PersonEntity:
          Name:
            NameFull: Olivier J
      – PersonEntity:
          Name:
            NameFull: Touzet H
      – PersonEntity:
          Name:
            NameFull: de Launoit Y
      – PersonEntity:
          Name:
            NameFull: Tian TV
      – PersonEntity:
          Name:
            NameFull: Duterque-Coquillaud M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 129
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1